Annual EBITDA
$7.80 B
-$1.05 B-11.85%
31 December 2023
Summary:
Gilead Sciences annual earnings before interest, taxes, depreciation & amortization is currently $7.80 billion, with the most recent change of -$1.05 billion (-11.85%) on 31 December 2023. During the last 3 years, it has risen by +$3.67 billion (+88.80%). GILD annual EBITDA is now -66.72% below its all-time high of $23.45 billion, reached on 31 December 2015.GILD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$1.19 B
-$1.79 B-59.99%
30 September 2024
Summary:
Gilead Sciences quarterly earnings before interest, taxes, depreciation & amortization is currently $1.19 billion, with the most recent change of -$1.79 billion (-59.99%) on 30 September 2024. Over the past year, it has dropped by -$2.04 billion (-63.08%). GILD quarterly EBITDA is now -79.92% below its all-time high of $5.95 billion, reached on 31 December 2015.GILD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$3.23 B
-$2.04 B-38.72%
30 September 2024
Summary:
Gilead Sciences TTM earnings before interest, taxes, depreciation & amortization is currently $3.23 billion, with the most recent change of -$2.04 billion (-38.72%) on 30 September 2024. Over the past year, it has dropped by -$7.46 billion (-69.79%). GILD TTM EBITDA is now -86.23% below its all-time high of $23.45 billion, reached on 31 December 2015.GILD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.8% | -63.1% | -69.8% |
| 3 y3 years | +88.8% | -71.7% | -73.8% |
| 5 y5 years | -24.3% | +232.1% | -51.8% |
GILD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -31.1% | +88.8% | -71.7% | +133.7% | -73.8% | at low |
| 5 y | 5 years | -31.1% | +88.8% | -71.7% | +133.7% | -73.8% | +79.5% |
| alltime | all time | -66.7% | +7461.5% | -79.9% | +133.7% | -86.2% | +3146.3% |
Gilead Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.19 B(-60.0%) | $3.23 B(-38.7%) |
| June 2024 | - | $2.98 B(-184.2%) | $5.27 B(+10.1%) |
| Mar 2024 | - | -$3.54 B(-236.6%) | $4.78 B(-54.4%) |
| Dec 2023 | $7.80 B(-11.9%) | $2.59 B(-19.8%) | $10.50 B(-1.8%) |
| Sept 2023 | - | $3.23 B(+29.4%) | $10.69 B(+0.5%) |
| June 2023 | - | $2.50 B(+15.2%) | $10.64 B(+2.2%) |
| Mar 2023 | - | $2.17 B(-22.1%) | $10.41 B(+17.6%) |
| Dec 2022 | $8.85 B(-21.9%) | $2.79 B(-12.6%) | $8.85 B(+16.5%) |
| Sept 2022 | - | $3.19 B(+40.4%) | $7.60 B(-11.9%) |
| June 2022 | - | $2.27 B(+271.5%) | $8.62 B(-3.6%) |
| Mar 2022 | - | $611.00 M(-60.1%) | $8.95 B(-21.0%) |
| Dec 2021 | $11.33 B(+174.1%) | $1.53 B(-63.6%) | $11.33 B(-7.9%) |
| Sept 2021 | - | $4.21 B(+62.5%) | $12.30 B(+29.4%) |
| June 2021 | - | $2.59 B(-13.4%) | $9.51 B(+109.7%) |
| Mar 2021 | - | $2.99 B(+19.4%) | $4.53 B(+9.7%) |
| Dec 2020 | $4.13 B(-45.3%) | $2.51 B(+77.1%) | $4.13 B(+0.3%) |
| Sept 2020 | - | $1.42 B(-159.4%) | $4.12 B(+129.0%) |
| June 2020 | - | -$2.38 B(-191.9%) | $1.80 B(-75.0%) |
| Mar 2020 | - | $2.59 B(+4.0%) | $7.19 B(-4.9%) |
| Dec 2019 | $7.56 B(-26.6%) | $2.49 B(-375.9%) | $7.56 B(+12.9%) |
| Sept 2019 | - | -$904.00 M(-130.1%) | $6.70 B(-38.5%) |
| June 2019 | - | $3.01 B(+1.5%) | $10.89 B(+2.8%) |
| Mar 2019 | - | $2.96 B(+81.7%) | $10.59 B(+2.7%) |
| Dec 2018 | $10.30 B(-35.3%) | $1.63 B(-50.4%) | $10.30 B(-10.3%) |
| Sept 2018 | - | $3.29 B(+21.3%) | $11.49 B(-7.8%) |
| June 2018 | - | $2.71 B(+1.0%) | $12.47 B(-13.7%) |
| Mar 2018 | - | $2.68 B(-5.0%) | $14.44 B(-9.4%) |
| Dec 2017 | $15.93 B(-17.1%) | $2.82 B(-33.8%) | $15.93 B(-9.4%) |
| Sept 2017 | - | $4.26 B(-9.0%) | $17.59 B(-3.1%) |
| June 2017 | - | $4.68 B(+12.2%) | $18.15 B(-1.2%) |
| Mar 2017 | - | $4.17 B(-6.8%) | $18.38 B(-4.4%) |
| Dec 2016 | $19.22 B(-18.0%) | $4.48 B(-7.1%) | $19.22 B(-7.1%) |
| Sept 2016 | - | $4.82 B(-1.9%) | $20.69 B(-5.0%) |
| June 2016 | - | $4.91 B(-2.1%) | $21.79 B(-4.4%) |
| Mar 2016 | - | $5.01 B(-15.6%) | $22.80 B(-2.8%) |
| Dec 2015 | $23.45 B(+43.7%) | $5.95 B(+0.5%) | $23.45 B(+5.9%) |
| Sept 2015 | - | $5.92 B(-0.2%) | $22.14 B(+10.9%) |
| June 2015 | - | $5.92 B(+4.6%) | $19.96 B(+6.7%) |
| Mar 2015 | - | $5.66 B(+22.1%) | $18.71 B(+14.7%) |
| Dec 2014 | $16.32 B(+235.8%) | $4.63 B(+23.8%) | $16.32 B(+25.6%) |
| Sept 2014 | - | $3.74 B(-19.9%) | $13.00 B(+24.1%) |
| June 2014 | - | $4.67 B(+43.1%) | $10.48 B(+49.0%) |
| Mar 2014 | - | $3.27 B(+148.5%) | $7.03 B(+44.6%) |
| Dec 2013 | $4.86 B(+14.3%) | $1.31 B(+7.5%) | $4.86 B(+2.8%) |
| Sept 2013 | - | $1.22 B(-0.3%) | $4.73 B(+2.4%) |
| June 2013 | - | $1.23 B(+11.9%) | $4.62 B(+2.2%) |
| Mar 2013 | - | $1.10 B(-7.2%) | $4.51 B(+6.2%) |
| Dec 2012 | $4.25 B(+2.2%) | $1.18 B(+6.3%) | $4.25 B(+5.3%) |
| Sept 2012 | - | $1.11 B(-1.2%) | $4.04 B(+0.5%) |
| June 2012 | - | $1.13 B(+35.2%) | $4.02 B(+0.5%) |
| Mar 2012 | - | $832.27 M(-14.0%) | $3.99 B(-4.0%) |
| Dec 2011 | $4.16 B(-3.0%) | $967.27 M(-11.3%) | $4.16 B(+1.2%) |
| Sept 2011 | - | $1.09 B(-1.1%) | $4.11 B(+0.7%) |
| June 2011 | - | $1.10 B(+10.7%) | $4.08 B(+0.8%) |
| Mar 2011 | - | $996.72 M(+8.6%) | $4.05 B(-5.6%) |
| Dec 2010 | $4.29 B(+13.3%) | $917.66 M(-13.7%) | $4.29 B(-4.9%) |
| Sept 2010 | - | $1.06 B(-0.6%) | $4.51 B(+2.2%) |
| June 2010 | - | $1.07 B(-13.5%) | $4.41 B(+5.8%) |
| Mar 2010 | - | $1.24 B(+8.4%) | $4.17 B(+10.2%) |
| Dec 2009 | $3.78 B(+30.8%) | $1.14 B(+18.2%) | $3.78 B(+8.6%) |
| Sept 2009 | - | $965.47 M(+16.8%) | $3.48 B(+8.2%) |
| June 2009 | - | $826.62 M(-2.9%) | $3.22 B(+5.6%) |
| Mar 2009 | - | $851.62 M(+1.4%) | $3.05 B(+4.5%) |
| Dec 2008 | $2.89 B(+30.6%) | $839.67 M(+19.6%) | $2.92 B(+12.1%) |
| Sept 2008 | - | $702.35 M(+6.9%) | $2.60 B(+5.7%) |
| June 2008 | - | $657.02 M(-8.8%) | $2.46 B(+4.2%) |
| Mar 2008 | - | $720.38 M(+37.5%) | $2.36 B(+6.7%) |
| Dec 2007 | $2.22 B | $523.95 M(-6.9%) | $2.22 B(+1.2%) |
| Sept 2007 | - | $562.56 M(+0.9%) | $2.19 B(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $557.46 M(-2.5%) | $2.05 B(+9.6%) |
| Mar 2007 | - | $571.82 M(+15.1%) | $1.87 B(+11.2%) |
| Dec 2006 | $1.68 B(+47.0%) | $496.99 M(+17.0%) | $1.68 B(+8.0%) |
| Sept 2006 | - | $424.79 M(+12.4%) | $1.56 B(+11.9%) |
| June 2006 | - | $377.90 M(-1.3%) | $1.39 B(+7.2%) |
| Mar 2006 | - | $382.89 M(+3.0%) | $1.30 B(+13.4%) |
| Dec 2005 | $1.14 B(+75.6%) | $371.71 M(+43.2%) | $1.14 B(+21.7%) |
| Sept 2005 | - | $259.58 M(-8.6%) | $940.55 M(+10.5%) |
| June 2005 | - | $283.93 M(+23.7%) | $850.86 M(+16.4%) |
| Mar 2005 | - | $229.61 M(+37.1%) | $731.14 M(+12.2%) |
| Dec 2004 | $651.79 M(+85.8%) | $167.43 M(-1.4%) | $651.79 M(+12.7%) |
| Sept 2004 | - | $169.89 M(+3.5%) | $578.50 M(+17.4%) |
| June 2004 | - | $164.21 M(+9.3%) | $492.94 M(+11.7%) |
| Mar 2004 | - | $150.27 M(+59.6%) | $441.45 M(+25.8%) |
| Dec 2003 | $350.78 M(+267.6%) | $94.13 M(+11.6%) | $350.78 M(+19.6%) |
| Sept 2003 | - | $84.33 M(-25.2%) | $293.38 M(+18.0%) |
| June 2003 | - | $112.72 M(+89.1%) | $248.72 M(+56.8%) |
| Mar 2003 | - | $59.60 M(+62.3%) | $158.62 M(+66.2%) |
| Dec 2002 | $95.44 M(-190.0%) | $36.73 M(-7.4%) | $95.44 M(+153.6%) |
| Sept 2002 | - | $39.66 M(+75.3%) | $37.63 M(-209.7%) |
| June 2002 | - | $22.63 M(-731.2%) | -$34.31 M(-60.7%) |
| Mar 2002 | - | -$3.58 M(-83.0%) | -$87.23 M(-17.7%) |
| Dec 2001 | -$106.00 M(+163.0%) | -$21.08 M(-34.7%) | -$106.00 M(+5.7%) |
| Sept 2001 | - | -$32.27 M(+6.6%) | -$100.25 M(+16.3%) |
| June 2001 | - | -$30.29 M(+35.5%) | -$86.20 M(+47.4%) |
| Mar 2001 | - | -$22.36 M(+45.8%) | -$58.47 M(+55.2%) |
| Dec 2000 | -$40.31 M(+3.1%) | -$15.33 M(-15.9%) | -$37.67 M(+247.4%) |
| Sept 2000 | - | -$18.23 M(+614.7%) | -$10.84 M(-32.3%) |
| June 2000 | - | -$2.55 M(+63.7%) | -$16.01 M(-29.7%) |
| Mar 2000 | - | -$1.56 M(-113.6%) | -$22.77 M(-34.5%) |
| Dec 1999 | -$39.10 M(-39.9%) | $11.50 M(-149.1%) | -$34.77 M(-45.6%) |
| Sept 1999 | - | -$23.40 M(+151.4%) | -$63.97 M(+19.4%) |
| June 1999 | - | -$9.31 M(-31.4%) | -$53.57 M(-15.5%) |
| Mar 1999 | - | -$13.56 M(-23.4%) | -$63.36 M(+3.4%) |
| Dec 1998 | -$65.10 M(+14.4%) | -$17.70 M(+36.2%) | -$61.30 M(-17.5%) |
| Sept 1998 | - | -$13.00 M(-31.9%) | -$74.30 M(-1.7%) |
| June 1998 | - | -$19.10 M(+66.1%) | -$75.60 M(+32.2%) |
| Mar 1998 | - | -$11.50 M(-62.5%) | -$57.20 M(+0.7%) |
| Dec 1997 | -$56.90 M(+80.1%) | -$30.70 M(+114.7%) | -$56.80 M(+51.1%) |
| Sept 1997 | - | -$14.30 M(+1942.9%) | -$37.60 M(+121.2%) |
| June 1997 | - | -$700.00 K(-93.7%) | -$17.00 M(-44.1%) |
| Mar 1997 | - | -$11.10 M(-3.5%) | -$30.40 M(-3.5%) |
| Dec 1996 | -$31.60 M(+9.7%) | -$11.50 M(-282.5%) | -$31.50 M(+57.5%) |
| Sept 1996 | - | $6.30 M(-144.7%) | -$20.00 M(-43.0%) |
| June 1996 | - | -$14.10 M(+15.6%) | -$35.10 M(+21.5%) |
| Mar 1996 | - | -$12.20 M(+38.6%) | -$28.90 M(-9.7%) |
| Dec 1995 | -$28.80 M(-8.0%) | - | - |
| Sept 1995 | - | -$8.80 M(+11.4%) | -$32.00 M(+6.0%) |
| June 1995 | - | -$7.90 M(-11.2%) | -$30.20 M(+2.4%) |
| Mar 1995 | - | -$8.90 M(+39.1%) | -$29.50 M(+2.1%) |
| Mar 1995 | -$31.30 M(+17.2%) | - | - |
| Dec 1994 | - | -$6.40 M(-8.6%) | -$28.90 M(-1.0%) |
| Sept 1994 | - | -$7.00 M(-2.8%) | -$29.20 M(+3.2%) |
| June 1994 | - | -$7.20 M(-13.3%) | -$28.30 M(+7.2%) |
| Mar 1994 | -$26.70 M(+61.8%) | -$8.30 M(+23.9%) | -$26.40 M(+7.3%) |
| Dec 1993 | - | -$6.70 M(+9.8%) | -$24.60 M(+11.8%) |
| Sept 1993 | - | -$6.10 M(+15.1%) | -$22.00 M(+14.6%) |
| June 1993 | - | -$5.30 M(-18.5%) | -$19.20 M(+17.8%) |
| Mar 1993 | -$16.50 M(+211.3%) | -$6.50 M(+58.5%) | -$16.30 M(-4.1%) |
| Dec 1992 | - | -$4.10 M(+24.2%) | -$17.00 M(+37.1%) |
| Sept 1992 | - | -$3.30 M(+37.5%) | -$12.40 M(+39.3%) |
| June 1992 | - | -$2.40 M(-66.7%) | -$8.90 M(+41.3%) |
| Mar 1992 | -$5.30 M(+32.5%) | -$7.20 M(-1540.0%) | -$6.30 M(+57.5%) |
| Dec 1991 | - | $500.00 K(+150.0%) | -$4.00 M(-9.1%) |
| Sept 1991 | - | $200.00 K(0.0%) | -$4.40 M(-2.2%) |
| June 1991 | - | $200.00 K(-104.1%) | -$4.50 M(-2.2%) |
| Mar 1991 | -$4.00 M | -$4.90 M(-5000.0%) | -$4.60 M(-1633.3%) |
| Dec 1990 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Sept 1990 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1990 | - | $100.00 K | $100.00 K |
FAQ
- What is Gilead Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Gilead Sciences?
- What is Gilead Sciences annual EBITDA year-on-year change?
- What is Gilead Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Gilead Sciences?
- What is Gilead Sciences quarterly EBITDA year-on-year change?
- What is Gilead Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Gilead Sciences?
- What is Gilead Sciences TTM EBITDA year-on-year change?
What is Gilead Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GILD is $7.80 B
What is the all time high annual EBITDA for Gilead Sciences?
Gilead Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is $23.45 B
What is Gilead Sciences annual EBITDA year-on-year change?
Over the past year, GILD annual earnings before interest, taxes, depreciation & amortization has changed by -$1.05 B (-11.85%)
What is Gilead Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of GILD is $1.19 B
What is the all time high quarterly EBITDA for Gilead Sciences?
Gilead Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.95 B
What is Gilead Sciences quarterly EBITDA year-on-year change?
Over the past year, GILD quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.04 B (-63.08%)
What is Gilead Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of GILD is $3.23 B
What is the all time high TTM EBITDA for Gilead Sciences?
Gilead Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $23.45 B
What is Gilead Sciences TTM EBITDA year-on-year change?
Over the past year, GILD TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.46 B (-69.79%)